What is the VHIO?
The Vall d'Hebron Institute of Oncology (VHIO), which is part of the Vall d'Hebron Campus, is a center for personalized medicine in oncology.
Our objective is to carry out research to improve the prevention, early diagnosis and treatment of cancer thanks to a pioneering model of translational research.
More than 700 professionals from multiple disciplines work together to find solutions to the needs of cancer patients, with the mission of developing new and more effective treatments that improve their quality of life.
Join our team!
A unique professional career
At VHIO you can develop a unique career in a competitive environment, contributing together with the whole team to promote cancer research and improve the treatment of patients.
Join our project!
Workplace and culture
Working at VHIO means being part of a purposeful project, in an environment of innovation and collaboration. Here, every day is an opportunity to make a real difference in people's lives, working side by side with professionals with great passion and commitment.
What do we offer?
-
📈The opportunity to develop your professional career in a competitive environment.
-
🧠To be part of a center that is in constant development, seeking excellence in research and collaborating with leading teams.
-
🫱🏻🫲🏾We offer and promote a diverse and inclusive environment, and welcome all people equally, regardless of age, disability, gender, nationality, race, religion or sexual orientation.
-
✨VHIO has been awarded the HR Excellence in Research Badge (link a la sección) that identifies the institutions and organisations as providers and supporters of a stimulating and favourable working environment for Research.
-
🪴We care about our environment and understand the importance of sustainability. We have the GreenVhio program, which you can be a part of.
Vacantes disponibles
About VHIO
The Vall d'Hebron Institute of Oncology (VHIO) is a leading center for personalized cancer medicine.
Thanks to its pioneering model of multidisciplinary and translational research, as well as its participation in consortia and projects with other prestigious centers worldwide, it has become one of the most important comprehensive centers in Europe. VHIO is able to rapidly translate the latest laboratory research discoveries into early-phase clinical trials, and thus, into new opportunities for patients.